跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
卓乐定 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ziprasidone Hydrochloride Capsules
Approved
化学药品
Ziprasidone Hydrochloride Capsules
Viatris Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jan 2, 2020
Approval ID
7MazXc33ve1
Company
Viatris Pharma GmbH
Type
化学药品
Approval Details
Approval Id
7MazXc33ve1
Approval Number
H20160410
Generic Name
盐酸齐拉西酮胶囊
Generic Name En
Ziprasidone Hydrochloride Capsules
Trade Name
卓乐定
Brand Name
卓乐定
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
20mg(按齐拉西酮计)
Reg Date
2020-01-02
Expired Date
2025-01-01
Company Name
Viatris Pharma GmbH
Company Address
Lütticher Strasse 5, 53842 Troisdorf, Federal Republic of Germany
Production Company Name
Pfizer Ireland Pharmaceuticals
Production Company Address
Little Connell, Newbridge, Co. Kildare, Ireland
Company Detail Path
/organization/viatris-pharma-gmbh
Production Company Detail Path
/organization/pfizer-ireland-pharmaceuticals
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 2, 2020
Approval ID
7MazXc33ve1
Type
化学药品
Back to NMPA Approvals